Vistakon Pharmaceuticals
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Vistakon Pharmaceuticals sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).
Vistakon Pharmaceuticals: 13 sponsored US clinical trials, none currently recruiting.
Vistakon Pharmaceuticals sponsors 13 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 13 completed. 10 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis, with 1 trials.
Top-decile sponsor footprint
Vistakon Pharmaceuticals ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
13 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
13 total, page 1 of 1
Safety and Efficacy of a Drug Delivery System in Glaucoma
NCT01016691
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
NCT00889252
Safety and Efficacy Study of a Eye Drop for Eye Allergy
NCT00889330
A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
NCT00823043
Safety and Efficacy of a Glaucoma Drug Delivery System
NCT00824720
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT00804648
Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers
NCT00569777
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis
NCT00445874
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
NCT00432757
Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
NCT00364091
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
NCT00244543
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
NCT00241319
Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
NCT00223951
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 9 |
| Phase 4 | 1 |
How the Vistakon Pharmaceuticals archive is shaped
13 indexed studies, none listed as recruiting (0% open); 13 completed (100%).
Phase mix: 10 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Vistakon Pharmaceuticals: archived-pipeline peers nationwide
Peers matched on 13 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Vistakon Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 13 archived trials
- Adaptimmune · 13 trials · 0% recruiting
- Agennix · 13 trials · 0% recruiting
- Akili Interactive Labs · 13 trials · 0% recruiting
- Alumis · 13 trials · 8% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Vistakon Pharmaceuticals page
13 registered trials is a research-attention snapshot, not an endorsement of Vistakon Pharmaceuticals or any single study.
- None of Vistakon Pharmaceuticals's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis is the condition Vistakon Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Vistakon Pharmaceuticals pipeline card: 13 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.